In this study, we aimed to define the ferroptosis susceptibility of CLL cells, investigate how the stromal microenvironment influences ferroptosis resistance, and evaluate whether targeted therapies such as BTK and BCL2 inhibitors modulate ferroptosis-induced cell death. Here, BCL2 is linked to B-cell chronic lymphocytic leukemia.